BEAVERTON, Ore., Aug. 22, 2019 /PRNewswire/ -- The following statement is being issued by The Association for the Treatment of Sexual Abusers:The country has understandably been shocked and appalled by the heinous actions, both confirmed and alleged, involving the sexual abuse and trafficking of children perpetrated by Jeffrey Epstein

NEW YORK, Aug. 22, 2019 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate's top priority is seeing to it that a Navy Veteran with mesothelioma recei

BOSTON, Aug. 22, 2019 /PRNewswire/ -- meQuilibrium research found that burnout is a common problem in the workplace, with 25% of survey respondents at high risk for b

LOS ALAMOS, N.M., Aug. 22, 2019 /PRNewswire/ -- Knoze Jr. (https://allerpops.com/) is advising their customers to that using AllerPops a couple of times before the allergy season

SOUTH SAN FRANCISCO, Calif., Aug. 22, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the Company will participate in the following conferences in September.Citi's 14th Annual Biotech Conference on Wednesday, September 4, 2019, in

STERLING, Va., Aug. 22, 2019 /PRNewswire/ --Aperiomics, the fast-growing biotech company combining the latest advancements in science, technology, and medicine to change the way healthcare providers ide

LAKEWAY, Texas, Aug. 22, 2019 /PRNewswire/ -- JFL Capital Management, LLC, together with its affiliates and the other participants in its solicitation, the largest stockholder of Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") (NASDAQ: MACK), with ownership of approximately 18.7% of the Company's outstanding shares, announced today that it has issued a let

SUMMIT, N.J., Aug. 22, 2019 /PRNewswire/ -- Seqirus, a global leader in influenza prevention, today announced it will feature data in 3 presentations and 24 posters on the company's adjuvant and cell-based vaccines for seasonal and pandemic influenza at the Options for the Control of Influenza (OPTIONS X) Conference in Singapore.

ENGLEWOOD, Colo., Aug. 22, 2019 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a special protocol assessment (SPA) phase three clinical trial titled, "A Randomized, Controlled, Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of Ampion™ in Adult

SAN FRANCISCO, Aug. 22, 2019 /PRNewswire/ -- CrossBay Medical, Inc., today announced that it has received clearance to commercialize its product, the Endometrial Tissue Sampler using CrossGlide™ technology, in Europe by obtaining its CE Mark. The use of this technology allows a novel way to obtain an office-based endometrial bi